Profile data is unavailable for this security.
About the company
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
- Revenue in USD (TTM)3.19m
- Net income in USD-10.42m
- Incorporated2016
- Employees13.00
- LocationIntelligent Bio Solutions Inc135 W 41St St,, Floor 5NEW YORK 10036United StatesUSA
- Phone+1 (646) 233-6971
- Fax+1 (302) 575-1642
- Websitehttps://ibs.inc/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NLS Pharmaceutics AG | 0.00 | -6.60m | 6.66m | 3.00 | -- | -- | -- | -- | -6.72 | -6.72 | 0.00 | -9.40 | 0.00 | -- | -- | 0.00 | -380.82 | -272.62 | -- | -- | -- | -- | -- | -- | -- | -27.20 | -- | -- | -- | -- | 26.21 | -- | -- | -- |
| National Graphite Corp | 0.00 | -1.97m | 6.79m | 0.00 | -- | -- | -- | -- | -0.0221 | -0.0221 | 0.00 | -0.0193 | 0.00 | -- | -- | -- | -11,014.44 | -212.13 | -- | -6,295.18 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1,432.70 | -- | -- | -- |
| Edesa Biotech Inc | 0.00 | -6.93m | 6.85m | 16.00 | -- | 2.39 | -- | -- | -2.21 | -2.21 | 0.00 | 0.8829 | 0.00 | -- | -- | 0.00 | -94.60 | -- | -128.81 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 52.28 | -- | -- | -- |
| Cannabis Bioscience Internatnl Hlgs Inc | 354.91k | -545.87k | 6.86m | 2.00 | -- | -- | -- | 19.33 | -0.00005 | -0.00005 | 0.00003 | -0.0001 | 8.98 | -- | 15.71 | 177,455.00 | -1,381.60 | -- | -- | -- | 87.28 | -- | -153.81 | -- | -- | -2.16 | -- | -- | -21.46 | -- | 36.92 | -- | -- | -- |
| Virpax Pharmaceuticals Inc | 0.00 | -13.24m | 6.91m | 7.00 | -- | -- | -- | -- | -8.82 | -8.82 | 0.00 | -0.4198 | 0.00 | -- | -- | 0.00 | -198.45 | -87.52 | -594.46 | -116.56 | -- | -- | -- | -- | -- | -128.86 | -- | -- | -- | -- | 29.84 | -- | -- | -- |
| Syros Pharmaceuticals Inc | 386.00k | -97.82m | 6.98m | 68.00 | -- | -- | -- | 18.07 | -3.03 | -3.03 | 0.0105 | -0.4145 | 0.0033 | -- | -- | 5,676.47 | -84.04 | -54.44 | -111.15 | -64.32 | -- | -- | -25,340.67 | -772.82 | -- | -179.01 | 1.37 | -- | -33.23 | 37.12 | -73.87 | -- | -27.78 | -- |
| Biora Therapeutics Inc | 892.00k | -35.57m | 7.07m | 58.00 | -- | -- | -- | 7.93 | -12.92 | -11.78 | 0.2163 | -28.99 | 0.0363 | -- | 1.06 | 15,379.31 | -144.59 | -122.84 | -- | -369.01 | -- | -- | -3,988.12 | -415.10 | -- | -- | -- | -- | -98.69 | -87.44 | -154.63 | -- | -53.68 | -- |
| Plus Therapeutics Inc (USA) | 5.73m | -12.89m | 7.08m | 20.00 | -- | -- | -- | 1.24 | -2.42 | -2.42 | 0.988 | -0.8775 | 0.5653 | -- | -- | 286,250.00 | -127.22 | -59.18 | -- | -133.04 | -- | -- | -225.07 | -470.45 | -- | -4.31 | -- | -- | 2,093.30 | -5.89 | 34.32 | -- | 3.77 | -- |
| ABVC Biopharma Inc | 509.80k | -8.24m | 7.14m | 16.00 | -- | 0.8363 | -- | 14.00 | -0.9744 | -0.9744 | 0.0508 | 0.6576 | 0.0328 | -- | 1.60 | 31,862.50 | -56.14 | -103.38 | -88.09 | -231.54 | 72.54 | 76.25 | -1,710.03 | -2,019.89 | -- | -2.62 | 0.1856 | -- | -84.28 | 85.39 | 35.97 | -- | -- | -- |
| Intelligent Bio Solutions Inc | 3.19m | -10.42m | 7.19m | 13.00 | -- | 1.18 | -- | 2.26 | -27.94 | -27.94 | 1.42 | 1.39 | 0.3121 | 1.93 | 5.56 | 245,228.50 | -102.35 | -71.59 | -255.70 | -144.36 | 48.31 | -- | -327.90 | -565.48 | 1.01 | -- | 0.0775 | -- | 147.58 | 596.39 | 4.47 | -- | -- | -- |
| Cardio Diagnostics Holdings Inc | 35.69k | -8.25m | 7.57m | 7.00 | -- | 2.04 | -- | 212.12 | -0.3853 | -0.3853 | 0.0016 | 0.1215 | 0.0068 | -- | 4.94 | 5,098.57 | -158.03 | -- | -229.86 | -- | -- | -- | -23,124.35 | -- | -- | -27.40 | 0.00 | -- | 1,696.84 | -- | -79.72 | -- | -- | -- |
| Vincerx Pharma Inc | 0.00 | -27.03m | 7.60m | 42.00 | -- | 0.8825 | -- | -- | -1.03 | -1.03 | 0.00 | 0.2901 | 0.00 | -- | -- | 0.00 | -131.14 | -- | -200.57 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 36.24 | -- | -- | -- |
| Evaxion Biotech A/S - ADR | 3.30m | -11.46m | 7.64m | 49.00 | -- | -- | -- | 2.32 | -16.80 | -16.80 | 0.8311 | -- | -- | -- | -- | 67,244.90 | -- | -100.11 | -- | -131.65 | -- | -- | -347.86 | -131,560.30 | -- | -- | -- | -- | -- | -- | 4.51 | -- | 65.53 | -- |
| Galecto Inc | 0.00 | -21.17m | 7.70m | 13.00 | -- | 0.3501 | -- | -- | -19.33 | -19.33 | 0.00 | 16.70 | 0.00 | -- | -- | 0.00 | -57.67 | -48.46 | -72.47 | -52.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.77 | -- | -- | -- |
| Mustang Bio Inc | 0.00 | -23.42m | 7.74m | 80.00 | -- | -- | -- | -- | -1.71 | -1.71 | 0.00 | -0.2298 | 0.00 | -- | -- | 0.00 | -168.70 | -70.02 | -- | -79.98 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 33.44 | -- | -60.75 | -- |
| Curative Biotechnology Inc | 0.00 | -6.02m | 7.76m | 4.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -339.98 | -- | -- | -- | -- | -- | -- | -- | -- | -5.51 | -- | -- | -- | -- | -302.92 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Intelligent Bio Solutions Inc's reporting currency: US Dollar USD
7.82%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Alyeska Investment Group LPas of 30 Sep 2024 | 206.20k | 4.85% |
| Heights Capital Management, Inc.as of 30 Jun 2024 | 79.84k | 1.88% |
| Geode Capital Management LLCas of 30 Sep 2024 | 22.71k | 0.53% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 15.49k | 0.36% |
| Adar1 Capital Management LLCas of 30 Sep 2024 | 5.39k | 0.13% |
| UBS Securities LLCas of 30 Sep 2024 | 1.55k | 0.04% |
| Tower Research Capital LLCas of 30 Sep 2024 | 1.06k | 0.03% |
| RBC Capital Markets LLC (Investment Management)as of 30 Sep 2024 | 55.00 | 0.00% |
| Bank of America, NA (Private Banking)as of 30 Sep 2024 | 25.00 | 0.00% |
| Altium Capital Management LPas of 30 Sep 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
